474 related articles for article (PubMed ID: 22436653)
1. Singing in groups for Parkinson's disease (SING-PD): a pilot study of group singing therapy for PD-related voice/speech disorders.
Shih LC; Piel J; Warren A; Kraics L; Silver A; Vanderhorst V; Simon DK; Tarsy D
Parkinsonism Relat Disord; 2012 Jun; 18(5):548-52. PubMed ID: 22436653
[TBL] [Abstract][Full Text] [Related]
2. Voice and choral singing treatment: a new approach for speech and voice disorders in Parkinson's disease.
Di Benedetto P; Cavazzon M; Mondolo F; Rugiu G; Peratoner A; Biasutti E
Eur J Phys Rehabil Med; 2009 Mar; 45(1):13-9. PubMed ID: 18987565
[TBL] [Abstract][Full Text] [Related]
3. The effect of group music therapy on mood, speech, and singing in individuals with Parkinson's disease--a feasibility study.
Elefant C; Baker FA; Lotan M; Lagesen SK; Skeie GO
J Music Ther; 2012; 49(3):278-302. PubMed ID: 23259231
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment.
Ramig LO; Fox C; Sapir S
Semin Speech Lang; 2004 May; 25(2):169-80. PubMed ID: 15118943
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of group voice therapy for individuals with Parkinson's disease.
Searl J; Wilson K; Haring K; Dietsch A; Lyons K; Pahwa R
J Commun Disord; 2011; 44(6):719-32. PubMed ID: 21889774
[TBL] [Abstract][Full Text] [Related]
6. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
[TBL] [Abstract][Full Text] [Related]
7. Voice improvement following conventional speech therapy combined with singing intervention in people with Parkinson's disease: A three-arm randomised controlled trial.
Mohseni Z; Mohamadi R; Habibi SAH; Saffarian A; Abolghasemi J
Int J Lang Commun Disord; 2023; 58(5):1752-1767. PubMed ID: 37282797
[TBL] [Abstract][Full Text] [Related]
8. [Communication disorders marked with hypophonia. Indication and speech therapy through the LSVT method].
Cabaret P; Sarfati J
Rev Laryngol Otol Rhinol (Bord); 2007; 128(5):325-8. PubMed ID: 20387379
[TBL] [Abstract][Full Text] [Related]
9. A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.
Sackley CM; Rick C; Au P; Brady MC; Beaton G; Burton C; Caulfield M; Dickson S; Dowling F; Hughes M; Ives N; Jowett S; Masterson-Algar P; Nicoll A; Patel S; Smith CH; Woolley R; Clarke CE;
Trials; 2020 May; 21(1):436. PubMed ID: 32460885
[TBL] [Abstract][Full Text] [Related]
10. ParkinSong: A Controlled Trial of Singing-Based Therapy for Parkinson's Disease.
Tamplin J; Morris ME; Marigliani C; Baker FA; Vogel AP
Neurorehabil Neural Repair; 2019 Jun; 33(6):453-463. PubMed ID: 31081485
[No Abstract] [Full Text] [Related]
11. Should singing activities be included in speech and voice therapy for prepubertal children?
Rinta T; Welch GF
J Voice; 2008 Jan; 22(1):100-12. PubMed ID: 16968664
[TBL] [Abstract][Full Text] [Related]
12. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease.
Rusz J; Cmejla R; Ruzickova H; Ruzicka E
J Acoust Soc Am; 2011 Jan; 129(1):350-67. PubMed ID: 21303016
[TBL] [Abstract][Full Text] [Related]
13. Studying vocal fold vibrations in Parkinson's disease with a nonlinear model.
Zhang Y; Jiang J; Rahn DA
Chaos; 2005 Sep; 15(3):33903. PubMed ID: 16252994
[TBL] [Abstract][Full Text] [Related]
14. Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease.
Halpern AE; Ramig LO; Matos CE; Petska-Cable JA; Spielman JL; Pogoda JM; Gilley PM; Sapir S; Bennett JK; McFarland DH
Am J Speech Lang Pathol; 2012 Nov; 21(4):354-67. PubMed ID: 23071195
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of Parkinson's-related dysphonia.
Sewall GK; Jiang J; Ford CN
Laryngoscope; 2006 Oct; 116(10):1740-4. PubMed ID: 17003722
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based treatment of voice and speech disorders in Parkinson disease.
Mahler LA; Ramig LO; Fox C
Curr Opin Otolaryngol Head Neck Surg; 2015 Jun; 23(3):209-15. PubMed ID: 25943966
[TBL] [Abstract][Full Text] [Related]
17. Effect of intensive voice treatment on tone-language speakers with Parkinson's disease.
Whitehill TL; Wong LL
Clin Linguist Phon; 2007; 21(11-12):919-25. PubMed ID: 17972188
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of vocal symptoms in Parkinson's disease: the Lee Silverman method].
Dias AE; Limongi JC
Arq Neuropsiquiatr; 2003 Mar; 61(1):61-6. PubMed ID: 12715021
[TBL] [Abstract][Full Text] [Related]
19. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
[TBL] [Abstract][Full Text] [Related]
20. Effects of the Lee Silverman Voice Treatment (LSVT® LOUD) on hypomimia in Parkinson's disease.
Dumer AI; Oster H; McCabe D; Rabin LA; Spielman JL; Ramig LO; Borod JC
J Int Neuropsychol Soc; 2014 Mar; 20(3):302-12. PubMed ID: 24524211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
